Anti-IL-18BP antibodies
US12365737B2 · kind B2 · utility
0Cited by
41References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2024 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Aug 27, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are antibodies that bind to interleukin-18 binding protein (IL-18BP) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.